| Basics |
| Company: |
Seer, Inc. |
| IPO Date: |
December 4, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$133.26M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.67 | 3.78%
|
| Avg Daily Range (30 D): |
$0.03 | 1.43%
|
| Avg Daily Range (90 D): |
$0.04 | 1.97%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.34M |
| Avg Daily Volume (30 D): |
.17M |
| Avg Daily Volume (90 D): |
.2M |
| Trade Size |
| Avg Trade Size (Sh.): |
84 |
| Avg Trade Size (Sh.) (30 D): |
128 |
| Avg Trade Size (Sh.) (90 D): |
136 |
| Institutional Trades |
| Total Inst.Trades: |
459 |
| Avg Inst. Trade: |
$2.42M |
| Avg Inst. Trade (30 D): |
$.98M |
| Avg Inst. Trade (90 D): |
$.98M |
| Avg Inst. Trade Volume: |
.1M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.23M |
| Avg Closing Trade (30 D): |
$9.87M |
| Avg Closing Trade (90 D): |
$9.87M |
| Avg Closing Volume: |
150.39K |
|
|
|
|
| News |
Feb 20, 2025 @ 12:00 PM
Seer to Feature Proteomic Advancements in Cancer a...
Source: N/A
|
Jun 11, 2024 @ 3:11 PM
Seer Proteographâ„¢ Provides Differentiated In...
Source: Seer, Inc.
|
Jun 2, 2024 @ 2:55 PM
Seer Technology Access Center Provides Unprecedent...
Source: Seer, Inc.
|
May 8, 2024 @ 10:45 PM
Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue ...
Source: Zacks Equity Research
|
May 8, 2024 @ 8:05 PM
Seer Reports First Quarter 2024 Financial Results
Source: Seer, Inc.
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-1.3
|
$-.35
|
$-.35
|
|
Diluted EPS
|
$-1.3
|
$-.35
|
$-.35
|
|
Revenue
|
$ 14.61M
|
$ 4.03M
|
$ 3.07M
|
|
Gross Profit
|
$ 7.03M
|
$ 1.94M
|
$ 1.73M
|
|
Net Income / Loss
|
$ -82.66M
|
$ -21.33M
|
$ -22.85M
|
|
Operating Income / Loss
|
$ -98.85M
|
$ -24.33M
|
$ -27.1M
|
|
Cost of Revenue
|
$ 7.58M
|
$ 2.09M
|
$ 1.34M
|
|
Net Cash Flow
|
$ 1.23M
|
$ 5.68M
|
$ -.55M
|
|
PE Ratio
|
|
|
|
|
